Recording and Reporting of Antimicrobial Resistance (AMR) Priority Variables and Its Implication on Expanding Surveillance Sites in Nepal: A CAPTURA Experience

Author:

Maharjan Sanju1ORCID,Gallagher Patrick2,Gautam Manish1,Joh Hea Sun3,Sujan Mohammad Julhas3,Aboushady Ahmed Taha34,Kwon Soo Young3,Gautam Sanjay35,Upadhyaya Madan Kumar6,Jha Runa7,Acharya Jyoti7,MacWright William R2,Marks Florian38910,Stelling John4,Poudyal Nimesh3

Affiliation:

1. Public Health Research , Anweshan Private Limited, Lalitpur , Nepal

2. Public Health Surveillance Group , LLC, Princeton, New Jersey , USA

3. International Vaccine Institute , Seoul , Republic of Korea

4. Brigham & Women's Hospital , Harvard Medical School, Boston, Massachusetts , USA

5. Research & Collaboration , Anka Analytica, Melbourne , Australia

6. Ministry of Health and Population , Government of Nepal, Kathmandu , Nepal

7. National Public Health Laboratory , Department of Health Services, Ministry of Health and Population, Kathmandu , Nepal

8. Cambridge Institute of Therapeutic Immunology and Infectious Disease , University of Cambridge School of Clinical Medicine, Cambridge , United Kingdom

9. Heidelberg Institute of Global Health , University of Heidelberg, Heidelberg , Germany

10. Madagascar Institute for Vaccine Research , University of Antananarivo , Madagascar

Abstract

Abstract Data on antimicrobial resistance (AMR) from sites not participating in the National AMR surveillance network, conducted by National Public Health Laboratory (NPHL), remain largely unknown in Nepal. The “Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia” (CAPTURA) assessed AMR data from previously untapped data sources in Nepal. A retrospective cross-sectional data review was carried out for the AMR data recorded between January 2017 and December 2019 to analyze AMR data from 26 hospital-based laboratories and 2 diagnostic laboratories in Nepal. Of the 56 health facilities initially contacted to participate in this project activity, 50.0% (28/56) signed a data-sharing agreement with CAPTURA. Eleven of the 28 hospitals were AMR surveillance sites, whereas the other 17, although not part of the National AMR surveillance network, recorded AMR-related data. Data for 663 602 isolates obtained from 580 038 patients were analyzed. A complete record of the 11 CAPTURA priority variables was obtained from 45.5% (5/11) of government hospitals, 63.6% (7/11) of private hospitals, and 54.6% (6/11) of public-private hospitals networked with NPHL for AMR surveillance. Similarly, 80% (8/10) of clinics and 54.6% (6/11) of laboratories outside the NPHL network recorded complete data for the 10 Global Antimicrobial Resistance and Use Surveillance System (GLASS) priority variables and 11/14 CAPTURA priority variables. Retrospective review of the data identified areas requiring additional resources and interventions to improve the quality of data on AMR in Nepal. Furthermore, we observed no difference in the priority variables reported by sites within or outside the NPHL network, thus suggesting that policies could be made to expand the surveillance system to include these sites without substantially affecting the government's budget.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3